Vaccine For Human Use

Professional Vaccine For Human Use manufacturer is located in China, including Lyophilized Vaccine For Human, Rabies Vaccine For Human Use, Vaccine For Human, etc.Our products get a good reputation in

Varicella Vaccine For Child

₹ 91 / Piece Get Latest Price

Varicella Vaccine(Live), freeze-dried Apply the most advanced cell factory technology in the world for scale production, which fully meet immunization demand of different people, providing reliable guarantee to prevent varicella. [Eligibles] Varicella susceptible individuals at the age between 1 year old to 12 years old. Varicella virus vaccine, live attenuated (oka strain) is indicated for: - The active immunization against varicella of healthy subjects from 12 months to 12 years of age - The active immunization against varicella of susceptible high-risk patients and their susceptible healthy close contacts in the age group of 12 months to 12 years . [Specifications] 0.5ml of reconstituted vaccine per container. 0.5ml per single human dose containing not less than 3.4Lg PFU Oka virus. [Interactions with other medicine]1) Use of whole blood, plasma or immunoglobuhns 5 months prior to the injection or within three weeks after injection is not recommended as it decrease the effect of the vaccine.2) In subjects who have received immune globulins or a blood tranfusion, vaccination should be delayed for at least three months because of the likelihood of vaccine failure due to passively acquired varicella antibodies.3) Usage of salicylates within 6 weeks of vaccination should be avoided.4) When administering with other live attenuated vaccines, should be administered either on the same day or at an interval of at least a month apart.

View Complete Details

Ask Latest Price & Details

Vero Cell Rabies Vaccine

₹ 91 / Piece Get Latest Price

Rabies is caused by the rabies virus. The virus infects the brain and ultimately leads to death. After being bitten by a rabid animal, the virus is deposited in the muscle and subcutaneous tissue. For most of the incubation period (which is usually one to three months), the virus stays close to the exposure site. The virus then travels via peripheral nerves to the brain and from there, again via peripheral nerves, to nearly all parts of the body. rabies vaccine is a vaccine used to prevent rabies.there are a number of vaccines available that are both safe and effective. They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite. The immunity that develops is long lasting after a full course. Doses are usually given by injection into the skin or muscle. After exposure vaccination is typically used along with rabies immunoglobulin. It is recommended that those who are at high risk of exposure be vaccinated before potential exposure. Vaccines are effective in humans . [eligibles] for prophylactic immunisation against rabies, treatment of patients following suspected rabies contact. If a person is bitten or scratched by a rabid dog or other rabid animal, regardless of age or sex, the wounds shall be cleaned immediately (flush the wounds repe.

View Complete Details

Ask Latest Price & Details

Rabies Vaccine For Human

₹ 91 / Piece Get Latest Price

Apply fixed bed bio-reactor DISKS micro-carrier-in high-density culture of VERO cell; realize scale production in international standard vaccine industrialization and reach international standard, contributing to early realization of rabies elimination goal. Advantages: 1)Obtain National Ten Famous-brand Products Honor Certificate in pharmaceutical industry; 2)Exclusively obtain the invention patent of Rabies Vaccine for Human Use, Freeze-driedand its preparation method; 3)Apply fixed bed bio-reactor DISKS micro-carrier to realize high-density culture of VERO cell, advanced technology process and high quality. 4)High titer and great stability. 5)With less clinical reaction, high-level immunogenicity, high conversion rate of serum antibody, high titer of antibody GMT, the Vaccine provides ideal protection after injection.6)5 doses for whole immunization process with standard operation and reliable effect for prevention; 7)Lyophilized dosage form for quality guarantee; 8)Exclusively apply two dosage forms of pre-filled syringe from American BD Company and vial pack for security and convenience;

View Complete Details

Ask Latest Price & Details

Rabies Vaccine After Bite

₹ 91 / Piece Get Latest Price

DIRECTIONS FOR USE OF RABIES VACCINE (VERO CELLS) FOR HUMAN USE, FREEZE-DRIED [Drug Name] Adopted name: Rabies Vaccine (Vero cells) for Human Use, Freeze-dried [Constituents and characters] The vaccine is a freeze-dried preparation of rabies fixed virus grown in Vero cells. After cultivation and harvest, the virus suspension is inactivated, concentrated and purified, and lyophilized after the addition of a suitable stabilizer. It looks like a white crisp cake. After reconstitution it turns into a clear liquid containing thimerosal as a preservative. [Function and use] The preparation can induce immunity against rabies virus in recipients following immunization. It is used to prevent rabies in human. [Specifications] 0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose. The potency of the vaccine shall be not less than 2.5 IU. [Adverse reactions] After inoculation, mild local or systemic reactions may occur, which could be relieved spontaneously. Occasionally rashes may appear. In case of some serious adverse reactions, such as immediate anaphylactic reactions, angioneurotic edema or urticaria, symptomatic treatment is recommended. [Contraindications] Because rabies is a fatal disease, there are no contraindications for post-exposure immunization. For pre-exposure immunization, it is not recommended to immunize eligible individuals with fever, acute disease, serious chronic disease, and with a histo

View Complete Details

Ask Latest Price & Details

Bulk Of Rabies Vaccine For Human Use

transportation shipment

Ready to fill bulk [Standard for implementation]Pharmacopoeia of the People's Republic of China Vol. 3, 2015 and the official standard of this product registration.[Manufacturing] 2. 1 Cell substrates for vaccine productionVero cells shall be used for the vaccine production2. 1. 1 Management and control tests on cell substrates.It complies with the Requirements for Preparation and Control of Animals Cell Substrates Used for Production of Biologics. The maximum passage number of the cells from cell banks at every level shall not exceed the approved limit.2. 1. 2 Cell substrate preparationThe cells from one or more containers of the working cell bank are resurrected to expand by serialsubculture up to a quantity enough for making one lot of vaccine. The quantity of the cells can bedefined as a cell batch. During the subculture of the cells, trypsin or other suitable digestion solution at an appropriate concentration is added onto the monolayer cell cultures to disperse cells. The dispersed cells are suspended evenly with suitable growth medium and distributed into culture bottles. Incubate the cells at 370C to form confluent monolayers.2. 2 Virus seeds2. 2. 1 Name and origin of virus strainsRabies fixed virus CTN-1V strain and aGV strain or other approved Vero cell-adapted rabies fixedvirus strain can be used as the seed for the vaccine production.2. 2. 2 Establishment of virus seed lot systemIt complies

View Complete Details

Ask Latest Price & Details

Meningococcal Polysaccharide Vaccine For Human

₹ 91 / Piece Get Latest Price

[Eligibles]Adults and children over two years of age.[Function and use]The vaccine is indicated for active immunization against invasive meningococcal disease caused by epidemic Neisseria meningitidis serogroups A, C, Y, W135.[Description]The vaccine is a preparation of preparation polysaccharide antigens extracted from the culture of Neisseria meningitidis group ACYW135 respectively and Iyophilized after addition of an appropriate stabilizer. The final product looks like a white crisp cake. It shall dissolve in the accompanying Phosphate buffered saline (PBS) immediately, and turn into a clear liquid after reconstitution.Active constituent: Neisseria meningitidis group ACYW135 capsular polysaccharides.Subsidiary materials: All the components of subsidiary materials approved shall be listed.Vaccine diluent: Sterile, pyrogen-free PBS.[Specifications]0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose, containing 200g of meningococcal polysaccharide (50g of each polysaccharide of group A, C, Y, W135).[Feature]Fill a gap in our country for the first time by developing 4-valent vaccine .Improve traditional purification technology to eliminate nucleic acid and protein.Improve WHO specifications and high harvest rate. Develop new type of stabilizer. Improve national quality standards.1.Group ACYW135 2.Group A+C

View Complete Details

Ask Latest Price & Details